Zeyuan H. Yu
Lanzhou, 730000, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 44 publications
Erratum to "Targeting the ANXA8-SP1-PPA1 Axis to Modulate TCA Cycle and Matrix Deposition in Diffuse-Type Gastric Cancer".
Journal: Research (Washington, D.C.)
Published: July 22, 2026
USP20 promotes CD8+ T cell exhaustion and impairs KRASG12D inhibitor efficacy by orchestrating cholesterol metabolism and autophagy in pancreatic cancer.
Journal: Gut
Published: January 27, 2026
A Real-Time Online Nomogram Integrating Systemic Inflammatory Response Index and Lactate Dehydrogenase to Predict Pathological Response in Gastric Cancer Patients Receiving Neoadjuvant Chemoimmunotherapy.
Journal: Cancer management and research
Published: August 08, 2025
UBE2T-Driven p53 Degradation Rewires Glycolysis to Orchestrate Lactylation-Mediated CAFs Activation and ECM Deposition in Pancreatic Cancer.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: August 06, 2025
Targeting the ANXA8-SP1-PPA1 Axis to Modulate TCA Cycle and Matrix Deposition in Diffuse-Type Gastric Cancer.
Journal: Research (Washington, D.C.)
Published: February 26, 2025
ULBP2 CAR-T cells enhance gastric cancer immunotherapy by inhibiting CAF activation.
Journal: Cell death & disease
Published: January 16, 2025
Targeting Posttranslational Modifications in the Tumor Stromal Microenvironment for Antitumor Therapy.
Journal: Molecular carcinogenesis
Published: January 09, 2025
Targeting Eg5 using Arry520 combats gastric cancer by inducing monopolar spindles.
Journal: Gene
Published: December 21, 2024
Biological Functions and Therapeutic Potential of UBE2T in Human Cancer.
Journal: Current cancer drug targets
Published: November 28, 2024
Extracorporeal membrane oxygenation ameliorate hepatic injury in brain death rat donors with hemodynamic instability.
Journal: The International journal of artificial organs
Published: October 14, 2024
Last Updated: 09/26/2026